Last reviewed · How we verify
Yangxin Shengmai
Yangxin Shengmai is a traditional Chinese medicine formulation that nourishes the heart and restores the pulse through qi and yin supplementation.
Yangxin Shengmai is a traditional Chinese medicine formulation that nourishes the heart and restores the pulse through qi and yin supplementation. Used for Cardiac arrhythmias and palpitations, Heart qi and yin deficiency syndromes.
At a glance
| Generic name | Yangxin Shengmai |
|---|---|
| Also known as | YXSM, YXSM placebo |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal compound is designed to tonify heart qi and yin deficiency, improve blood circulation, and regulate cardiac rhythm. It is used in traditional Chinese medicine to address palpitations, arrhythmias, and related cardiovascular symptoms by restoring balance to the heart system according to TCM principles.
Approved indications
- Cardiac arrhythmias and palpitations
- Heart qi and yin deficiency syndromes
Common side effects
Key clinical trials
- Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yangxin Shengmai CI brief — competitive landscape report
- Yangxin Shengmai updates RSS · CI watch RSS
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences portfolio CI